企業一覧に戻る

Corteva, IncCTVA)の決算・業績分析

Corteva, Incの2025年有価証券報告書をAI分析。売上高$17.4B(+2.9%)。Consumer Staples

目次
SUMMARY — 業績サマリー

Corteva, Inc2025年度 業績サマリー

Corteva, Inc(証券コード: CTVA)の2025年度決算・業績分析。売上高は$17.4B(前年比+2.9%)。純利益は$1.1B(前年比+20.6%)。有価証券報告書を基に、業績変化の要因・リスク・見通し・セグメント構成を AI が分析しました。

Corteva, Inc2024年度 注目ポイント

※ 直近の2025年度XBRLデータは取込済みですが、AI分析は2024年度の10-Kを対象としています。

  1. Revenue grew 11.5% YoY to $17.5B (XBRL), but net income fell 34.8% YoY to $1.1B (XBRL).
  2. Operating margin remained stable at 15.1% (XBRL), while cash conversion cycle (CCC) extended to 180 days (XBRL).
  3. Shareholder returns totaled $1.4B (XBRL), with $1.0B in share repurchases (XBRL) and $418M in dividends (XBRL).

Corteva, Incの売上高変化の要因

  • Total revenue reached $17.5B (XBRL), reflecting +11.5% YoY growth. Historical data shows revenue increased from $14.3B (FY2020) to $17.5B (FY2024), though FY2025 guidance is $17.2B (10-K). No segment or product line breakdown is available (XBRL), and growth drivers are not quantified in the data.

Corteva, Incの営業利益変化の要因

  • Operating income was $2.6B (XBRL) with a 15.1% margin (XBRL). EBITDA totaled $3.9B (22.1% margin) (XBRL). Net income declined 34.8% YoY to $1.1B (XBRL), though gross profit and cost structure details are not provided (XBRL). Net margin was 6.6% (XBRL).

Corteva, Incの事業リスクと対応

Regulatory approval risks may restrict sales and increase costs (10-K).

Non-compliance with evolving regulatory standards could harm sales and profitability (10-K).

Uncertainty in approvals for novel technologies may reduce R&D returns (10-K).

Lawsuits from environmental groups could challenge product registrations (10-K).

Dependence on successful pipeline product development for growth (10-K).

Corteva, Incの今後の見通し・業績予想

Management provided FY2025 revenue guidance of $17.2B (10-K). Key risks include regulatory approvals, competition, geopolitical conflicts, and environmental litigation (10-K).

Corteva, Incの事業内容

Corteva, Inc. (CTVA) operates in the agricultural sector, providing Seed and Crop Protection solutions to enhance farmer productivity (10-K). Its revenue model relies on selling technology-based and solution-based agricultural products and services (10-K). Key customers are farmers in 110 countries (10-K), with no significant customer concentration noted (10-K). Competitive advantages include a broad new product pipeline, scientific heritage, and direct engagement with farmers (10-K).

Corteva, IncのAI業績分析レポート(2024年度)

Corteva, Inc. (CTVA) FY2024 Annual Report Analysis

Highlights

Revenue grew 11.5% YoY to $17.5B (XBRL), but net income fell 34.8% YoY to $1.1B (XBRL).
Operating margin remained stable at 15.1% (XBRL), while cash conversion cycle (CCC) extended to 180 days (XBRL).
Shareholder returns totaled $1.4B (XBRL), with $1.0B in share repurchases (XBRL) and $418M in dividends (XBRL).

Business Overview

Corteva, Inc. (CTVA) operates in the agricultural sector, providing Seed and Crop Protection solutions to enhance farmer productivity (10-K). Its revenue model relies on selling technology-based and solution-based agricultural products and services (10-K). Key customers are farmers in 110 countries (10-K), with no significant customer concentration noted (10-K). Competitive advantages include a broad new product pipeline, scientific heritage, and direct engagement with farmers (10-K).

Revenue Analysis

Total revenue reached $17.5B (XBRL), reflecting +11.5% YoY growth. Historical data shows revenue increased from $14.3B (FY2020) to $17.5B (FY2024), though FY2025 guidance is $17.2B (10-K). No segment or product line breakdown is available (XBRL), and growth drivers are not quantified in the data.

Profitability Analysis

Operating income was $2.6B (XBRL) with a 15.1% margin (XBRL). EBITDA totaled $3.9B (22.1% margin) (XBRL). Net income declined 34.8% YoY to $1.1B (XBRL), though gross profit and cost structure details are not provided (XBRL). Net margin was 6.6% (XBRL).

Balance Sheet Analysis

Equity ratio was 58.2% (XBRL), with total equity at $25.0B (XBRL) and total assets at $43.0B (XBRL). Current ratio was 1.56x (XBRL). Cash reserves stood at $2.6B (XBRL). ROE was 4.6% (XBRL), and ROA was 2.7% (XBRL).

Cash Flow Analysis

Operating cash flow was $872M (XBRL), while free cash flow (FCF) was $240M (XBRL). Investing cash flow was -$632M (XBRL), and financing cash flow was -$1.2B (XBRL). Depreciation and amortization (D&A) totaled $1.2B (XBRL). Shareholder returns included $418M in dividends (XBRL) and $1.0B in share repurchases (XBRL).

Working Capital Analysis

CCC was 180 days (XBRL), with receivables days at 88 days (XBRL), inventory days at 241 days (XBRL), and payables days at 150 days (XBRL).

Risks

Regulatory approval risks may restrict sales and increase costs (10-K).
Non-compliance with evolving regulatory standards could harm sales and profitability (10-K).
Uncertainty in approvals for novel technologies may reduce R&D returns (10-K).
Lawsuits from environmental groups could challenge product registrations (10-K).
Dependence on successful pipeline product development for growth (10-K).

Outlook

Management provided FY2025 revenue guidance of $17.2B (10-K). Key risks include regulatory approvals, competition, geopolitical conflicts, and environmental litigation (10-K).

Consumer Staplesの企業一覧

Corteva, Incと同じ「Consumer Staples」セクターの企業